Home › Asset managers › Direxion Shares ETF Trust › 2025-2026 › Against the board
784 proposals in the 2025-2026 proxy season: Direxion Shares ETF Trust voted against, or withheld its votes from, 762 proposals put forward by company boards, and voted for 22 shareholder proposals, by its own Form N-PX filings.
Two kinds of vote are listed: a board-sponsored proposal Direxion Shares ETF Trust voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
784 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Direxion Shares ETF Trust voted | Funds |
|---|---|---|---|---|---|---|---|
| PDD Holdings Inc. | December 19, 2025 | Elect Director Haifeng Lin | Director Elections | Board | AGAINST | 1 | |
| PDD Holdings Inc. | December 19, 2025 | Elect Director Jiazhen Zhao | Director Elections | Board | AGAINST | 1 | |
| PDD Holdings Inc. | December 19, 2025 | Elect Director Lei Chen | Director Elections | Board | AGAINST | 1 | |
| Pacific Premier Bancorp, Inc. | July 21, 2025 | Approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to the named executive officers of Pacific Premier in connection with the transactions contemplated by the merger agreement. | Say-on-Pay | Board | AGAINST | 1 | |
| Pacira Biosciences, Inc. | June 9, 2026 | Approval of our Amended and Restated 2011 Stock Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Pacira Biosciences, Inc. | June 9, 2026 | Approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Palvella Therapeutics, Inc. | June 10, 2026 | Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares. | Compensation | Board | AGAINST | 1 | |
| Par Pacific Holdings, Inc. | April 30, 2026 | To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Park National Corporation | April 27, 2026 | Approval of the Park National Corporation 2026 Long-Term Incentive Plan for Employees. | Compensation | Board | AGAINST | 1 | |
| Parsons Corporation | April 14, 2026 | Election of Directors: Letitia A. Long | Director Elections | Board | WITHHOLD | 1 | |
| Perspective Therapeutics, Inc. | May 27, 2026 | Election of Directors: Heidi Henson | Director Elections | Board | WITHHOLD | 1 | |
| Perspective Therapeutics, Inc. | May 27, 2026 | Election of Directors: Robert Froman Williamson, III | Director Elections | Board | WITHHOLD | 1 | |
| Phathom Pharmaceuticals, Inc. | May 19, 2026 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta | Director Elections | Board | WITHHOLD | 1 | |
| Phibro Animal Health Corporation | November 4, 2025 | Election of Class III Directors: Alejandro Bernal | Director Elections | Board | WITHHOLD | 1 | |
| Phibro Animal Health Corporation | November 4, 2025 | Election of Class III Directors: E. Thomas Corcoran | Director Elections | Board | WITHHOLD | 1 | |
| Phibro Animal Health Corporation | November 4, 2025 | Election of Class III Directors: Jack C. Bendheim | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | A stockholder proposal to provide a political spending disclosure. | Other Social Issues | Shareholder | Against | FOR | 1 |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Andre Nogueira de Souza | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Gilberto Tomazoni | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Joanita Karoleski | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Joesley Mendonca Batista | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Wesley Mendonca Batista | Director Elections | Board | WITHHOLD | 1 | |
| Pilgrim's Pride Corporation | April 29, 2026 | Election of Directors: JBS Directors: Wesley Mendonca Batista Filho | Director Elections | Board | WITHHOLD | 1 | |
| PotlatchDeltic Corporation | January 27, 2026 | The PotlatchDeltic merger-related compensation proposal: A proposal to approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of PotlatchDeltic in connection with the transactions contemplated by the merger agreement. | Say-on-Pay | Board | AGAINST | 1 | |
| Precigen, Inc. | June 18, 2026 | Company Proposal - Election of Directors: Vinita Gupta | Director Elections | Board | AGAINST | 1 | |
| Prime Medicine, Inc. | June 5, 2026 | To elect Michael Kelly and David Schenkein, M.D. as Class I Directors: David Schenkein, M.D. | Director Elections | Board | WITHHOLD | 1 | |
| Protagonist Therapeutics, Inc. | June 17, 2026 | To approve the adoption of the Company's 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Protagonist Therapeutics, Inc. | June 17, 2026 | To elect the Class I director nominees named below to hold office until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dinesh V. Patel, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Qorvo, Inc. | August 13, 2025 | To approve, on an advisory basis, the compensation of our Named Executive Officers (as disclosed in the proxy statement). | Say-on-Pay | Board | AGAINST | 1 | |
| REGENXBIO Inc. | May 29, 2026 | Election of three Class II Directors: Jean Bennett, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| REGENXBIO Inc. | May 29, 2026 | To approve a stock option exchange for our executive employees. | Compensation | Board | AGAINST | 1 | |
| REGENXBIO Inc. | May 29, 2026 | To approve a stock option exchange for our non-executive employees. | Compensation | Board | AGAINST | 1 | |
| RXO, Inc. | May 12, 2026 | Approval of an Amendment to the RXO, Inc. 2022 Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 | |
| Recursion Pharmaceuticals, Inc. | June 17, 2026 | Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Recursion Pharmaceuticals, Inc. | June 17, 2026 | Election of Directors: Franziska Michor, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Recursion Pharmaceuticals, Inc. | June 17, 2026 | Election of Directors: Najat Khan, Ph.D. | Director Elections | Board | WITHHOLD | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | A non-binding advisory vote to approve the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | Election of five (5) Directors: Christopher R. Moe | Director Elections | Board | WITHHOLD | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | Election of five (5) Directors: General (R) Paul E. Funk II | Director Elections | Board | WITHHOLD | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | Election of five (5) Directors: Jeffrey M. Thompson | Director Elections | Board | WITHHOLD | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | Election of five (5) Directors: Joseph Freedman | Director Elections | Board | WITHHOLD | 1 | |
| Red Cat Holdings, Inc. | June 18, 2026 | Election of five (5) Directors: Nicholas Liuzza Jr. | Director Elections | Board | WITHHOLD | 1 | |
| Redwire Corporation | May 20, 2026 | Election of Class II Directors: Reggie Brothers | Director Elections | Board | WITHHOLD | 1 | |
| Relay Therapeutics, Inc. | June 9, 2026 | To elect two class III directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: Douglas S. Ingram | Director Elections | Board | WITHHOLD | 1 | |
| RenaissanceRe Holdings Ltd. | May 5, 2026 | To approve the RenaissanceRe Holdings Ltd. 2026 Long-Term Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Repligen Corporation | May 14, 2026 | Election of Directors: Carrie Eglinton Manner | Director Elections | Board | AGAINST | 1 | |
| Repligen Corporation | May 14, 2026 | Election of Directors: Glenn P. Muir | Director Elections | Board | AGAINST | 1 | |
| Repligen Corporation | May 14, 2026 | Election of Directors: Karen A. Dawes | Director Elections | Board | AGAINST | 1 | |
| Replimune Group, Inc. | September 3, 2025 | To approve an amendment to Replimune Group, Inc.'s 2018 Omnibus Incentive Compensation Plan (the "Plan Amendment"). | Compensation | Board | AGAINST | 1 | |
| Rezolute, Inc. | November 19, 2025 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Rhythm Pharmaceuticals, Inc. | June 24, 2026 | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company. | Say-on-Pay | Board | AGAINST | 1 | |
| Rigel Pharmaceuticals, Inc. | May 14, 2026 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Compensation | Board | AGAINST | 1 | |
| Roblox Corporation | May 28, 2026 | Advisory Vote on the Compensation of our Named Executive Officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Roblox Corporation | May 28, 2026 | Election of Class II Directors: David Baszucki | Director Elections | Board | WITHHOLD | 1 | |
| Roblox Corporation | May 28, 2026 | Election of Class II Directors: Gregory Baszucki | Director Elections | Board | WITHHOLD | 1 | |
| Rocket Lab Corporation | August 27, 2025 | Election of Class I Directors: Jon Olson | Director Elections | Board | WITHHOLD | 1 | |
| Rocket Lab Corporation | August 27, 2025 | Election of Class I Directors: Merline Saintil | Director Elections | Board | WITHHOLD | 1 | |
| Rocket Lab Corporation | August 27, 2025 | To approve, on a non-binding advisory basis, the compensation of our named executive officers disclosed in the accompanying proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Rocket Lab Corporation | May 20, 2026 | Election of Class II Director Nominee: To be elected for term expiring in 2029: Edward H. Frank | Director Elections | Board | WITHHOLD | 1 | |
| Rocket Pharmaceuticals, Inc. | May 20, 2026 | The approval of the proposed stock option exchange program; and | Compensation | Board | AGAINST | 1 | |
| SELLAS Life Sciences Group, Inc. | June 16, 2026 | The advisory approval of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Sable Offshore Corp. | June 10, 2026 | To elect one Class II director, Gregory Pipkin, to hold office until our 2029 annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal: Gregory P. Pipkin | Director Elections | Board | WITHHOLD | 1 | |
| Sana Biotechnology, Inc. | June 4, 2026 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop | Director Elections | Board | WITHHOLD | 1 | |
| Sarepta Therapeutics, Inc. | June 4, 2026 | Advisory vote to approve, on a non-binding basis, named executive officer compensation | Say-on-Pay | Board | AGAINST | 1 | |
| Schneider National, Inc. | April 30, 2026 | Approval of amended and restated 2017 Schneider National, Inc. Omnibus Incentive Compensation Plan. | Compensation | Board | AGAINST | 1 | |
| Scholar Rock Holding Corporation | June 4, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Scholar Rock Holding Corporation | June 4, 2026 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: David Hallal | Director Elections | Board | WITHHOLD | 1 | |
| Science Applications International Corporation | June 3, 2026 | The approval of an amendment to the 2023 Equity Incentive Plan to increase the total number of authorized shares. | Compensation | Board | AGAINST | 1 | |
| Septerna, Inc. | June 26, 2026 | To elect two Class II directors to our board of directors, each to serve until our 2029 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Shalini Sharp | Director Elections | Board | WITHHOLD | 1 | |
| Service Corporation International | May 6, 2026 | Election of Directors: Marcus A. Watts | Director Elections | Board | AGAINST | 1 | |
| Service Corporation International | May 6, 2026 | To approve the 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 1 | |
| Shift4 Payments, Inc. | June 12, 2026 | Approval of the Company's 2026 Employee Stock Purchase Plan. | Compensation | Board | AGAINST | 1 | |
| Shift4 Payments, Inc. | June 12, 2026 | Election of Class III Directors: Jonathan Halkyard | Director Elections | Board | WITHHOLD | 1 | |
| Shift4 Payments, Inc. | June 12, 2026 | Election of Class III Directors: Nancy Disman | Director Elections | Board | WITHHOLD | 1 | |
| SiTime Corporation | May 29, 2026 | To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement. | Say-on-Pay | Board | AGAINST | 1 | |
| Silicon Laboratories Inc. | April 23, 2026 | To approve amendments to the 2009 Stock Incentive Plan; and | Compensation | Board | AGAINST | 1 | |
| SkyWest, Inc. | May 5, 2026 | A shareholder proposal regarding collective bargaining policy. | Human Rights or Human Capital/workforce | Shareholder | Against | FOR | 1 |
| Snowflake Inc. | June 29, 2026 | Election of Class III Directors for terms expiring in 2029: Mark D. McLaughlin | Director Elections | Board | WITHHOLD | 1 | |
| Snowflake Inc. | June 29, 2026 | Election of Class III Directors for terms expiring in 2029: Sridhar Ramaswamy | Director Elections | Board | WITHHOLD | 1 | |
| Snowflake Inc. | June 29, 2026 | Election of Class III Directors for terms expiring in 2029: Teresa Briggs | Director Elections | Board | WITHHOLD | 1 | |
| Snowflake Inc. | June 29, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Somnigroup International, Inc. | May 13, 2026 | ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS; AND | Say-on-Pay | Board | AGAINST | 1 | |
| Somnigroup International, Inc. | May 13, 2026 | APPROVAL OF AN AMENDMENT TO THE COMPANY'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 500,000,000 TO 1,000,000,000. | Capital Structure | Board | AGAINST | 1 | |
| Sonoco Products Company | April 15, 2026 | Advisory (non-binding) shareholder proposal - avoid brand damage from political spending. | Other Social Issues | Shareholder | Against | FOR | 1 |
| Spyre Therapeutics, Inc. | May 27, 2026 | Election of Class I Directors for terms expiring in 2029: Laurie Stelzer | Director Elections | Board | WITHHOLD | 1 | |
| Stellar Bancorp, Inc. | May 27, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Stellar's named executive officers that is based on or otherwise relates to the merger. | Say-on-Pay | Board | AGAINST | 1 | |
| Stifel Financial Corp. | June 9, 2026 | To approve the adoption of an amendment to the Stifel Financial Corp. 2001 Incentive Stock Plan (2018 Restatement) | Compensation | Board | AGAINST | 1 | |
| Stoke Therapeutics, Inc. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Brian P. Brooks | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Carl J. Rickertsen | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Gregg J. Winiarski | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Jane A. Dietze | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Jarrod M. Patten | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Michael J. Saylor | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Phong Q. Le | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To elect the following eight (8) directors for the next year: Stephen X. Graham | Director Elections | Board | WITHHOLD | 1 | |
| Strategy Inc | June 8, 2026 | To ratify, pursuant to Section 204 of the General Corporation Law of the State of Delaware, the filing and effectiveness of the Certificate of Amendment to the Certificate of Designations of the Company's 8.00% Series A Perpetual Strike Preferred Stock filed with the Secretary of State of the State of Delaware on July 7, 2025, and the amendment to the liquidation preference of such stock effectuated thereby. | Capital Structure | Board | AGAINST | 1 | |
| Summit Therapeutics Inc. | June 10, 2026 | Approval of an amendment to the Summit Therapeutics Inc. 2020 Stock Incentive Plan to Increase the Number of Shares of Common Stock. | Compensation | Board | AGAINST | 1 | |
| Summit Therapeutics Inc. | June 10, 2026 | Approval, by a non-binding advisory vote, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 1 | |
| Summit Therapeutics Inc. | June 10, 2026 | ELECTION OF DIRECTORS: Kenneth A. Clark | Director Elections | Board | WITHHOLD | 1 |
← Previous Page 7 of 8 Next →
← Back to Direxion Shares ETF Trust 2025-2026 overview
Built November 7, 2026 from SEC Form N-PX filings.